Methyl eugenol - The current Bête Noire of aromatherapy

International Journal of Aromatherapy

Volumn 12, Issue 4, 2002, Pages 193-201

  Harris, Bob ^a  

^a Au Village   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESSENTIAL OIL; ESTRAGOLE; EUGENOL; METHYL EUGENOL; SAFROLE; UNCLASSIFIED DRUG;

ACUTE DISEASE; ALTERNATIVE MEDICINE; CANCER RISK; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CARCINOGENICITY; DRUG DNA BINDING; DRUG EXCRETION; DRUG EXPOSURE; DRUG METABOLISM; DRUG SAFETY; DRUG STRUCTURE; GASTROINTESTINAL TOXICITY; HUMAN; LIVER INJURY; LIVER TOXICITY; LIVER TUMOR; LOW DRUG DOSE; NONHUMAN; REVIEW; SEX DIFFERENCE; WEIGHT GAIN;

EID: 0036984164     PISSN: 09624562     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-4562(03)00006-7     Document Type: Review

References (31)

1. Abdo, K. M.; Cunningham, M. L.; Snell, M. L.; Herbert, R. A.; Travlos, G. S.; Eldridge, S. R. and Bucher, J. R. (2001). 14-Week toxicity and cell proliferation of methyl eugenol administered by gavage to F344 rats and B6C3F1 mice. Food Chem. Toxicol., 39: 303-316.
2. Anthony, A., Caldwell, J., Hutt, A. J. and Smith, R. L. (1987). Metabolism of estragole in rat and mouse and influence of dose size on excretion of the proximate carcinogen 1′-hydroxyestragole. Food Chem. Toxicol., 25, 799-806.
3. Boberg, E. W., Miller, E. C., Miller, J. A., Poland, A. and Liem, A. (1983). Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1′-sulfooxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1′-hydroxysafrole in mouse liver. Cancer Res., 43: 5163-5173.
4. Borchert, P., Wisloki, P. G., Miller, J. A. and Miller, E. C. (1973). Metabolism of the naturally occurring hepatocarcinogen safrole to 1′-hydroxysafrole and the electrophilic reactivity of 1′-acetoxysafrole. Cancer Res., 33: 575-689.
5. Burkey, J. F., Sauer, M., McQueen, C. A. and Sipes, I. G. (2000). Cytotoxicity and genotoxicity of methyleugenol and related congeners - A mechanism of activation for methyleugenol. Mut. Res., 453: 25-33.
6. Chan, V. S. W. and Caldwell, J. (1992). Comparative induction of unscheduled DNA synthesis in cultured rat hepatocytes by allylbenzenes and their 1′-hydroxy metabolites. Food Chem. Toxicol., 30: 831-836.
7. Drinkwater, N. R., Miller, E. C., Miller, J. A. and Pitot, H. C. (1976). Hepatocarcinogenicity of estragole (1-allyl-4-methoxybenzene) and 1′-hydroxyestragole in the mouse and mutagenicity of 1′-acetoestragole in bacteria. J. Nat. Cancer Inst., 57: 1323-1331.
8. Gardner, I., Bergin, P., Stening, P., Kenna, J. G. and Caldwel, J. (1995). Protein adducts derived from methyl eugenol. Fourth ISSX International Meeting, August 208.
9. Gardner, I., Bergin, P., Stening, P., Kenna, J. G. and Caldwel, J. (1996). Immunochemical detection of covalently modified protein adducts in livers of rats treated with methyleugenol. Crit. Rev. Toxicol., 9: 713-721.
10. Gardner, I. B., Blench, I., Morris, H. R., Caldwell, J. and Kenna, J. G. (1997). Covalent modification of the laminin receptor precursor protein by reactive metabolites of methyleugenol. Sixth ISSX International Meeting, November 244.
11. Hagan, E. C., Hansen, W. H., Fitzhugh, O. G., Jenner, P. M., Jones, W. I., Taylor, J. M., Long, E. L., Nelson, A. M and Brouwer, J. B. (1967). Food flavourings and compounds of related structure. II. Subacute and chronic toxicity. Food Cosmet. Toxicol., 5: 141-157.
12. 1 mice. J. Agric. Food Chem., 48: 3620-3632.
13. Lawrence, B. M. (1998-2002). Progress in Essential Oils, Perfumer & Flavorist, Allured.
14. Long, E. L. and Jenner, P. M. (1963). Esophageal tumours produced in rats by the feeding of dihydrosafrole. Federation Proc. Abstracts, 22: 275.
15. Luo, G. and Guenther, T. M. (1995). Metabolism of allylbenzene 2′,3′-oxide and estragole 2′,3′-oxide in the isolated perfused rat liver. J. Pharmacol. Exp. Therapeut., 272: 588-596.
16. Miele, M., Dondaro, R., Ciarallo, G. and Mazzei, M. (2001). Methyl eugenol in Ocimum basilicum L. Cv, Genovese Gigante. J. Agric. Food Chem., 49: 517-521.
17. Miller, E.C., Swanson, A.B., Phillips, D.H., Fletcher, T.L., Liem, A. and Miller, J. A. (1983). Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole. Cancer Res., 43: 1124-1134.
18. Miller, J.A., Miller, E.C. and Phillips, D.H. (1982). The metabolic activation and carcinogenicity of alkenylbenzenes that occur naturally in many spices. Carcin. Mut. Environ., 1: 83-96.
19. National Toxicology Program (2000). Toxicology and Carcinogenesis Studies of Methyleugenol (CAS No. 93-15-12) in F344/n Rats and B6C3F1 Mice (Gavage Studies). Draft NTP-TR-490; NIH Publication No. 98-3950.
20. Osborne, B.E., Plawiuk, C., Graham, C., Bier, G., Losos, B., Broxup, B.G., Procter. (1981). A 91-Day Single Dose Level Dietary Study of Eugenyl Mehyl Ether and Isoeugenyl Methyl Ether in the Albino Rat. Bioresearch Laboratories Ltd., Confidential Research Report No. 9203, FEMA (submitted).
21. 1 mice. Carcinogenesis, 5: 1623-1628.
22. 32P-Post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally occurring alkenylbenzenes. I. Adult female CD-1 mice. Carcinogenesis, 5: 1623-1628.
23. 14C)-labelled transanethole, estragole and p-propylanisole in human volunteers. Xenobiotica, 17: 1223-1232.
24. Sharma, R.A., Irelson, C.R., Verschoyle, R.D., Hill, K.A., Williams, M.L., Leuratti, C., Manson, M.M., Marnett, L.J. and Stewrad, W.P. (2001). Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: Relationship with drug levels. Clin. Cancer Res., 7: 1452-1458.
25. Sims, P. and Grover, P.L. (1974). In: Advances in Cancer Research. G. Kliem (Ed.):. Academic Press, New York.
26. Smith, R.L., Adams, T.B., Doull, J., Feron, V.J., Goodman, J.I., Marnet, L.J., Portoghese, P.S., Waddell, W.J., Wagner, B.M., Rogers, A.E., Caldwell, J. and Sipes, I.G. (2002). Safety assessment of allylalkoxybenzene derivatives used as flavouring substances - Methyl eugenol and estragole. Food Chem. Toxicol., 40: 851-870.
27. Solheim, E. and Scheline, R.R. (1973). Metabolism of alkenebenzene derivatives in the rat. II. Eugenol and isoeugenol methyl ethers. Xenobiotica, 6: 137-150.
28. Sutton, J.D., Sangster, S.A. and Caldwell, J. (1985). Dose-dependent variation in the disposition of eugenol in rat. Biochem. Pharmacol., 34: 465-466.
29. Swanson, A.B., Miller, E.C. and Miller, J.A. (1981). The side-chain epoxidation and hydro-xylation of the hepatocarcinogens safrole and estragole and some related compounds by rat and mouse liver microsomes. Biochim. Biophys. Acta, 673: 504-516.
30. 1 mice. Cancer Res., 47: 2275-2283.
31. Zangouras, A., Caldwell, J., Hutt, A.J. and Smith, R.L. (1981). Dosedependent conversion of estragole in the rat and mouse to the carcinogenic metabolite 1′-hydroxyestragole. Biochem. Pharmacol., 30: 1383-1386.